USDG0 brings fully backed, regulated stablecoin liquidity to high-growth DeFi environments, strengthening the next wave of onchain finance. Plume, the leading RWA blockchain powering real-world yield, today announced that it has joined Hyperliquid and Aptos as part of the inaugural launch cohort for USDG0 – a new omnichain version of the USDG stablecoin issued by […]

(Other OTC:FMCC),(OTC US:FMCC), MCLEAN, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily's loan purchase cap for 2026 will be $88 billion. The cap is set by U.S. Federal Housing largely based on projections for the size of the multifamily debt origination market. “Freddie Mac Multifamily delivers essential liquidity to create affordable

Freddie Mac Multifamily Loan Purchase Cap for 2026 is $88 Billion GlobeNewswire November 24, 2025 MCLEAN, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily's loan purchase cap for 2026 will be $88 billion. The cap is set by U.S. Federal Housing largely based on projections for the size of the multifamily

(NASDAQ:SNPS), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted by the recent departure of its Chief Revenue Officer (CRO). The company announced in a Form 8-K filing on November 4, 2025, that Rick

Toronto, Ontario–(Newsfile Corp. – Le 24 novembre/November 2025) - PreveCeutical Medical Inc. (“PreveCeutical”) has announced the effective date of the reclassification as well as the previously announced plan of arrangement with BioGene Therapeutics Inc. (“BioGene”) to occur on November 25, 2025. Pursuant to the Arrangement Agreement (the “Arrangement Agreement”) 12,000,000 common shares of BioGene Therapeutics Inc.

Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny– Hagens Berman SNPS Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted

New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public. SO WHAT:

(NASDAQ:TLX), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA

(NASDAQ:DXCM), RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025,

Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter — Hagens Berman TLX Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is